GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue
+3.71%
EPS
+10.2%
Free cash flow
−24.9%

Quarter to September 2026, against a year earlier

124.40 19.26 −13.41%
Market cap
$5.3B
P/E
0.0×
Fwd P/E
−14.5×
Dividend yield
—
F-score
6/9
Altman Z
0.37
Beneish M
n/a
Dividend safety
n/a

GRAIL, Inc. (GRAL) revenue by segment, product and region

Revenue by product or service $m

Line FY2025 FY2024 FY2023 FY2022
Screening revenue 139 109 75 40
Development Services 9 17 18 16
Revenue 147 126 93 56

Gross profit by product or service $m, and margin

Operating figures as reported in each quarter’s results release or filing

Figure Quarter Latest A year before Change
Galleri test volume Q3 FY2026 56.0K — —

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.